Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.
about
The Rise and Fall of Hyaluronan in Respiratory DiseasesThe wound healing, chronic fibrosis, and cancer progression triadAbnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease.A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.High molecular weight hyaluronan decreases oxidative DNA damage induced by EDTA in human corneal epithelial cells.Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosisHyaluronan as an immune regulator in human diseases.Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease.Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophagesEvidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosisFibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronanHyaluronan as a therapeutic target in human diseasesSerum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.High levels of hyaluronan in idiopathic pulmonary arterial hypertension.Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease.Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player?Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.Expression and purification of RHC-EGFP fusion protein and its application in hyaluronic acid assay.CD44: one ligand, two functions.Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis.Hyaluronan regulates bone morphogenetic protein-7-dependent prevention and reversal of myofibroblast phenotype.CD44 signaling through focal adhesion kinase and its anti-apoptotic effect.NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages.Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism.Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation.Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates.Lymphatic Vessels: The Next Frontier in Lung Transplant.Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.Clinical significance of serum hyaluronan in chronic fibrotic interstitial pneumonia.Innate immune signaling and stem cell renewal in idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
P2860
Q26786052-97D90953-F737-46F2-AD4B-3243AFACBA57Q27014616-EA0D8E61-6A94-4B4B-8168-F797939BC881Q30486123-3719A628-86A6-42C7-94FF-77788D1DBDA1Q33644088-084A3B87-8D52-4581-ADD2-23504058DB8EQ34116805-72DA5AD3-0318-4B83-9138-0E540503B29BQ34272980-AC474128-B87E-4D93-8272-38002B7B945BQ34560457-27C827BD-6408-4E28-AF20-985C86F3FAE1Q34636380-8FF8E809-DA48-408D-A7FD-3D659E8593AFQ35102315-09A6332D-2230-4110-9F9A-8DCDE0530815Q35272532-D3724639-703E-4623-93CB-D354D15C08D7Q35609982-20050737-035F-4D07-8833-1904CFBFFBBAQ36225851-06F3D601-15A6-4CFC-8725-C3B92CF24DBEQ36284401-2D4C975C-8892-40B8-9E42-FD124F302E65Q36499699-372304DC-1B9E-472D-92AB-7C49E53EC4E8Q36578627-472A2C23-E01C-4D43-9548-81C525091FB1Q36960794-3C3C7BFE-1231-41BF-A53C-8BEB1F3946B1Q36977316-F589CFA1-2930-42B9-B199-6EACFDBC966DQ37110889-325B5290-C70C-4B7F-8DE9-2992E1C051B7Q38638213-CFFECCB9-AE28-4158-8C4B-8B25D63B6C4BQ38688645-E06C91A5-E398-4E1F-A3AD-4A3F46E8C8FAQ38751292-15D6F078-977B-41F3-9D66-C553D13235A8Q39773522-20656143-E881-4A81-87E2-FDB666B651B4Q39774105-A04E135E-A14A-4D0F-8439-F9BE8D79F0A4Q39912001-4A975B91-28C2-47DE-B98E-02CB4B666F38Q40164945-28E9C430-A2D2-4A57-B7ED-5E3BE4D7B226Q40701709-D9630300-0DF1-458C-B41E-538940F312B1Q40704641-2047591A-298B-4E3A-9B37-FEC7BE67718DQ41120284-E05AFD15-6E98-47D7-8191-F2E26CE6A981Q41685163-480AC4BE-9AD3-42D2-B517-1EBEF13776A6Q42018558-4DB66B01-0407-4375-91CA-3AC7A0CDA186Q49847182-56CC76FD-98E2-4D07-B99E-A9CF02DC4C2AQ50782228-E6948E8F-CE68-40C5-89BE-881E83959E36Q50882865-02FB15E1-8A4E-4773-9051-682969A814ABQ51423230-9217F180-2E97-41A7-8832-9EA3EB6445F6Q52721106-6859BF11-4EFE-4159-9C6E-F5D2B5B806CEQ58735224-BF077EC7-DFEA-4901-B543-470C61187D7D
P2860
Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Hyaluronan and type III procol ...... idiopathic pulmonary fibrosis.
@ast
Hyaluronan and type III procol ...... idiopathic pulmonary fibrosis.
@en
type
label
Hyaluronan and type III procol ...... idiopathic pulmonary fibrosis.
@ast
Hyaluronan and type III procol ...... idiopathic pulmonary fibrosis.
@en
prefLabel
Hyaluronan and type III procol ...... idiopathic pulmonary fibrosis.
@ast
Hyaluronan and type III procol ...... idiopathic pulmonary fibrosis.
@en
P2093
P2860
P356
P1433
P1476
Hyaluronan and type III procol ...... idiopathic pulmonary fibrosis.
@en
P2093
P2860
P304
P356
10.1136/THX.44.2.126
P407
P577
1989-02-01T00:00:00Z